A muscarinic receptor antagonist reverses multiple indices of diabetic peripheral neuropathy: preclinical and clinical studies using oxybutynin

Anand P, Privitera R, Donatien P, Fadavi H, Tesfaye S, Bravis V et al (2022) Reversing painful and non-painful diabetic neuropathy with the capsaicin 8% patch: clinical evidence for pain relief and restoration of function via nerve fiber regeneration. Front Neurol 13:998904. https://doi.org/10.3389/fneur.2022.998904

Article  PubMed  PubMed Central  Google Scholar 

Appell RA, Chancellor MB, Zobrist RH, Thomas H, Sanders SW (2003) Pharmacokinetics, metabolism, and saliva output during transdermal and extended-release oral oxybutynin administration in healthy subjects. Mayo Clin Proc 78:696–702. https://doi.org/10.4065/78.6.696

Article  CAS  PubMed  Google Scholar 

Azmi S, Jeziorska M, Ferdousi M, Petropoulos IN, Ponirakis G, Marshall A et al (2019) Early nerve fibre regeneration in individuals with type 1 diabetes after simultaneous pancreas and kidney transplantation. Diabetologia 62:1478–1487. https://doi.org/10.1007/s00125-019-4897-y

Article  CAS  PubMed  PubMed Central  Google Scholar 

Bastyr EJ 3rd, Price KL, Bril V, Group MS (2005) Development and validity testing of the neuropathy total symptom score-6: questionnaire for the study of sensory symptoms of diabetic peripheral neuropathy. Clin Ther 27:1278–1294. https://doi.org/10.1016/j.clinthera.2005.08.002

Article  PubMed  Google Scholar 

Boyd A, Casselini C, Vinik E, Vinik A (2011) Quality of life and objective measures of diabetic neuropathy in a prospective placebo-controlled trial of ruboxistaurin and topiramate. J Diabetes Sci Technol 5:714–722. https://doi.org/10.1177/193229681100500326

Article  PubMed  PubMed Central  Google Scholar 

Boyd AL, Barlow PM, Pittenger GL, Simmons KF, Vinik AI (2010) Topiramate improves neurovascular function, epidermal nerve fiber morphology, and metabolism in patients with type 2 diabetes mellitus. Diabetes Metab Syndr Obes 3:431–437. https://doi.org/10.2147/DMSOTT.S13699

Article  CAS  PubMed  PubMed Central  Google Scholar 

Bril V (1999) NIS-LL: the primary measurement scale for clinical trial endpoints in diabetic peripheral neuropathy. Eur Neurol 41(Suppl 1):8–13. https://doi.org/10.1159/000052074

Article  PubMed  Google Scholar 

Calcutt NA, Smith DR, Frizzi K, Sabbir MG, Chowdhury SK, Mixcoatl-Zecuatl T et al (2017) Selective antagonism of muscarinic receptors is neuroprotective in peripheral neuropathy. J Clin Invest 127:608–622. https://doi.org/10.1172/JCI88321

Article  PubMed  PubMed Central  Google Scholar 

Casellini CM, Barlow PM, Rice AL, Casey M, Simmons K, Pittenger G et al (2007) A 6-month, randomized, double-masked, placebo-controlled study evaluating the effects of the protein kinase C-beta inhibitor ruboxistaurin on skin microvascular blood flow and other measures of diabetic peripheral neuropathy. Diabetes Care 30:896–902. https://doi.org/10.2337/dc06-1699

Article  CAS  PubMed  Google Scholar 

Casellini CM, Parson HK, Hodges K, Edwards JF, Lieb DC, Wohlgemuth SD et al (2016) Bariatric surgery restores cardiac and sudomotor autonomic C-fiber dysfunction towards normal in obese subjects with type 2 diabetes. PLoS ONE 11:e0154211. https://doi.org/10.1371/journal.pone.0154211

Article  CAS  PubMed  PubMed Central  Google Scholar 

Cerles O, Goncalves TC, Chouzenoux S, Benoit E, Schmitt A, Bennett Saidu NE et al (2019) Preventive action of benztropine on platinum-induced peripheral neuropathies and tumor growth. Acta Neuropathol Commun 7:9. https://doi.org/10.1186/s40478-019-0657-y

Article  PubMed  PubMed Central  Google Scholar 

Dhage S, Ferdousi M, Adam S, Ho JH, Kalteniece A, Azmi S et al (2021) Corneal confocal microscopy identifies small fibre damage and progression of diabetic neuropathy. Sci Rep 11:1859. https://doi.org/10.1038/s41598-021-81302-8

Article  CAS  PubMed  PubMed Central  Google Scholar 

Duong V, Iwamoto A, Pennycuff J, Kudish B, Iglesia C (2021) A systematic review of neurocognitive dysfunction with overactive bladder medications. Int Urogynecol J 32:2693–2702. https://doi.org/10.1007/s00192-021-04909-5

Article  PubMed  Google Scholar 

Ekman L, Thrainsdottir S, Englund E, Thomsen N, Rosen I, Hazer Rosberg DB et al (2020) Evaluation of small nerve fiber dysfunction in type 2 diabetes. Acta Neurol Scand 141:38–46. https://doi.org/10.1111/ane.13171

Article  CAS  PubMed  Google Scholar 

Emery SM, Dobrowsky RT (2016) Promoting neuronal tolerance of diabetic stress: modulating molecular chaperones. Int Rev Neurobiol 127:181–210. https://doi.org/10.1016/bs.irn.2016.03.001

Article  CAS  PubMed  PubMed Central  Google Scholar 

Ferreira-Valente MA, Pais-Ribeiro JL, Jensen MP (2011) Validity of four pain intensity rating scales. Pain 152:2399–2404. https://doi.org/10.1016/j.pain.2011.07.005

Article  PubMed  Google Scholar 

Gibbons CH, Illigens BM, Wang N, Freeman R (2010) Quantification of sudomotor innervation: a comparison of three methods. Muscle Nerve 42:112–119. https://doi.org/10.1002/mus.21626

Article  PubMed  PubMed Central  Google Scholar 

Gibbons CH, Zhu J, Zhang X, Habboubi N, Hariri R, Veves A (2021) Phase 2a randomized controlled study investigating the safety and efficacy of PDA-002 in diabetic peripheral neuropathy. J Peripher Nerv Syst 26:276–289. https://doi.org/10.1111/jns.12457

Article  CAS  PubMed  Google Scholar 

Goncalves NP, Vaegter CB, Andersen H, Ostergaard L, Calcutt NA, Jensen TS (2017) Schwann cell interactions with axons and microvessels in diabetic neuropathy. Nat Rev Neurol 13:135–147. https://doi.org/10.1038/nrneurol.2016.201

Article  CAS  PubMed  PubMed Central  Google Scholar 

Han MM, Frizzi KE, Ellis RJ, Calcutt NA, Fields JA (2021) Prevention of HIV-1 TAT protein-induced peripheral neuropathy and mitochondrial disruption by the antimuscarinic pirenzepine. Front Neurol 12:663373. https://doi.org/10.3389/fneur.2021.663373

Article  PubMed  PubMed Central  Google Scholar 

Jaiswal M, Martin CL, Brown MB, Callaghan B, Albers JW, Feldman EL et al (2015) Effects of exenatide on measures of diabetic neuropathy in subjects with type 2 diabetes: results from an 18-month proof-of-concept open-label randomized study. J Diabetes Complicat 29:1287–1294. https://doi.org/10.1016/j.jdiacomp.2015.07.013

Article  Google Scholar 

Jolivalt CG, Frizzi KE, Guernsey L, Marquez A, Ochoa J, Rodriguez M et al (2016) Peripheral neuropathy in mouse models of diabetes. Curr Protoc Mouse Biol 6:223–255. https://doi.org/10.1002/cpmo.11

Article  PubMed  PubMed Central  Google Scholar 

Jolivalt CG, Frizzi KE, Han MM, Mota AJ, Guernsey LS, Kotra LP et al (2020) Topical delivery of muscarinic receptor antagonists prevents and reverses peripheral neuropathy in female diabetic mice. J Pharmacol Exp Ther 374:44–51. https://doi.org/10.1124/jpet.120.265447

Article  CAS  PubMed  PubMed Central  Google Scholar 

Jolivalt CG, Han MM, Nguyen A, Desmond F, Alves Jesus CH, Vasconselos DC et al (2022) Using corneal confocal microscopy to identify therapeutic agents for diabetic neuropathy. J Clin Med. https://doi.org/10.3390/jcm11092307

Article  PubMed  PubMed Central  Google Scholar 

Kluding PM, Pasnoor M, Singh R, Jernigan S, Farmer K, Rucker J et al (2012) The effect of exercise on neuropathic symptoms, nerve function, and cutaneous innervation in people with diabetic peripheral neuropathy. J Diabetes Complicat 26:424–429. https://doi.org/10.1016/j.jdiacomp.2012.05.007

Article  Google Scholar 

Kobayashi M, Zochodne DW (2020) Diabetic polyneuropathy: Bridging the translational gap. J Peripher Nerv Syst 25:66–75. https://doi.org/10.1111/jns.12392

Article  CAS  PubMed  Google Scholar 

Lauria G, Bakkers M, Schmitz C, Lombardi R, Penza P, Devigili G et al (2010) Intraepidermal nerve fiber density at the distal leg: a worldwide normative reference study. J Peripher Nerv Syst 15:202–207. https://doi.org/10.1111/j.1529-8027.2010.00271.x

Article  PubMed  Google Scholar 

Lauria G, Hsieh ST, Johansson O, Kennedy WR, Leger JM, Mellgren SI et al (2010) European federation of neurological societies/peripheral nerve society guideline on the use of skin biopsy in the diagnosis of small fiber neuropathy: report of a joint task force of the European federation of neurological societies and the peripheral nerve society. Eur J Neurol 17:903–912. https://doi.org/10.1111/j.1468-1331.2010.03023.x

Article  CAS  PubMed  Google Scholar 

Leone Roberti Maggiore U, Salvatore S, Alessandri F, Remorgida V, Origoni M, Candiani M et al (2012) Pharmacokinetics and toxicity of antimuscarinic drugs for overactive bladder treatment in females. Expert Opin Drug Metab Toxicol 8:1387–1408. https://doi.org/10.1517/17425255.2012.714365

Article  CAS  PubMed  Google Scholar 

Macdiarmid SA (2009) The evolution of transdermal/topical overactive bladder therapy and its benefits over oral therapy. Rev Urol 11:1–6

PubMed  PubMed Central  Google Scholar 

Malik RA, Tesfaye S, Newrick PG, Walker D, Rajbhandari SM, Siddique I et al (2005) Sural nerve pathology in diabetic patients with minimal but progressive neuropathy. Diabetologia 48:578–585. https://doi.org/10.1007/s00125-004-1663-5

Article  CAS  PubMed  Google Scholar 

Malmberg AB, Mizisin AP, Calcutt NA, von Stein T, Robbins WR, Bley KR (2004) Reduced heat sensitivity and epidermal nerve fiber immunostaining following single applications of a high-concentration capsaicin patch. Pain 111:360–367. https://doi.org/10.1016/j.pain.2004.07.017

Article  CAS  PubMed 

留言 (0)

沒有登入
gif